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Abstract 
Pharmaceuticals are pseudo persistent aquatic pollutants 
with unknown effects at environmentally relevant 
concentrations. Gilthead seabream (Sparus aurata) were 
exposed to Acetaminophen (APAP): 31.90 ± 11.07; 
Atenolol (AT): 0.95 ± 0.38 and Carbamazepine (CBZ): 
6.95 ± 0.13 µg•L-1 for 28 days to (1) determine whether 
exposure to environmentally relevant concentrations of the 
pharmaceuticals alters the brain transcripome; and (2) 
identify different expression profiles and treatment specific 
modes of action and pathways. After APAP, AT and CBZ 
treatment, 411, 7 and 612 differently expressed transcripts 
were identified, respectively. Out of these, 248 features 
were common between APAP and CBZ and one between 
CBZ and AT. Two features were common across all 
treatments.  
Figure 1. Venn diagram representation of 
differentially expressed genes in the brain of 
APAP, AT and CBZ -treated seabream. Venn 
diagram shows the overlaps of differentially 
expressed genes based on at least a 1.5-fold 
filter change with a p≤0.05.  
Gene set enrichment analysis revealed effects on several biological process-, cellular compartment- and 
molecular function-related GO terms indicating towards known mechanisms from human and rodent 
exposures. Lysosome pathway, and androgen and estrogen metabolism were altered by APAP and CBZ, 
respectively. These data suggest (1) that exposure to environmentally relevant concentrations of the 
pharmaceuticals alters the brain’s gene expression profile of the seabream; (2) the existence of treatment 
specific processes that may be useful for biomarker development; and (3) that many responses observed 
in seabream are similar to humans.  
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